Jornal Brasileiro de Pneumologia
Print version ISSN 1806-3713
BALDI, Bruno Guedes et al. Evolution of pulmonary function after treatment with goserelin in patients with lymphangioleiomyomatosis. J. bras. pneumol. [online]. 2011, vol.37, n.3, pp. 375-379. ISSN 1806-3713. http://dx.doi.org/10.1590/S1806-37132011000300015.
In the atypical smooth muscle cells that are characteristic of lymphangioleiomyomatosis (LAM), there are estrogen and progesterone receptors. Therefore, anti-hormonal therapy, despite having produced controversial results, can be considered a treatment option. The objective of this retrospective study was to evaluate hormonal and spirometric data for nine women with LAM after one year of treatment with goserelin. The mean increase in FEV1 and FVC was 80 mL and 130 mL, respectively. There was effective blockage of the hormonal axis. It is still not possible to exclude a potential beneficial effect of the use of gonadotropin-releasing hormone analogues in LAM patients, which underscores the need for randomized trials
Keywords : Lymphangioleiomyomatosis; Spirometry; Goserelin.